Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

November 01, 2007 (Vol. 27, No. 19)

New Approaches Push Antibodies Ahead

Techniques Improve Optimization, Discovery, and Production Speeds

  • Antibody engineering is entering a new phase, moving from mouse to humanized and fully human antibodies. Novel technologies such as de novo generation of human antibodies, engineering techniques to increase antigen affinity, and production of antibody fragments are replacing standard methodologies. There are currently more than 150 companies ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.